Name: Successful Patient Input to Regulatory and Health Technology Assessment Processes Along the Development Path: Examples of How to Optimize Impact
Start: 2025-06-18T16:00:00-0400
End: 2025-06-18T17:00:00-0400

Wednesday June 18, 2025 4:00pm - 5:00pm EDT

TBD

Component Type: Session
Level: Intermediate

To guide patient focused drug development, patient input is sought by regulators and Health Technology Assessment (HTAs) in different ways around the world. The session will explore options to increase impact on development through greater coordination and information sharing.

Learning Objectives

Understand different options and processes for patient input into regulatory and HTA advice across key product development milestones. Explore best practices in maximising the overall impact of patient input on development plans. Identify policy and process changes that would allow continuous improvement and learning across the various set pieces for patient engagement.

Chair

Adam Heathfield, PhD

Speakers

Adam Heathfield

Senior Director, Patient and Health Impact, Pfizer

Adam has worked for Pfizer for over 10 years. His current role is Senior Director in Pfizer’s Patient and Health Impact division. Previously, Adam has worked in Pfizer’s international policy division and led Pfizer’s work on science policy in Europe for several years. Adam initially... Read More →

Wednesday June 18, 2025 4:00pm - 5:00pm EDT
TBD Walter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA

05: Patient-Impact-Product-Dev, Session

Format Session
Level Intermediate
Level Intermediate
format csv
Tags Session

DIA 2025 Global Annual Meeting

Adam Heathfield

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!